乳腺超声腺体组织成分与浸润性乳腺癌患者生存结局的关联
回顾性纳入2013年1月至2018年12月术前接受乳腺超声的2889例浸润性乳腺癌患者,将腺体组织成分定性分为低(轻微或轻度)与高(中度或明显)。高腺体组织成分与更差的无病生存期相关(HR 1.42),但与总生存期无关;绝经后组和三阴性乳腺癌亚组中高腺体组织成分与更差的总生存期和无病生存期均相关。
要点
- 术前乳腺超声评估腺体组织成分可分为低(轻微或轻度)与高(中度或明显)两类。
- 高腺体组织成分与更差的无病生存期独立相关(HR 1.42,95%CI 1.17–1.71,P<.001)。
- 绝经后及三阴性乳腺癌亚组中,高腺体组织成分与更差的总生存期和无病生存期相关。
核心结论
- 术前乳腺超声显示的腺体组织成分与浸润性乳腺癌患者的生存结局独立相关;若进一步验证,该发现可能有助于在临床实践中细化预后风险分层。
研究设计与样本
- 回顾性研究,纳入2013年1月至2018年12月间接受术前乳腺超声的2889例浸润性乳腺癌患者,腺体组织成分经超声定性评估分为低(轻微或轻度)和高(中度或明显),采用Cox比例风险回归模型评估其与无病生存期和总生存期的关联,并按绝经状态和分子亚型进行亚组分析。
诊断标准与关键数值
- 腺体组织成分定性评估分级:低为轻微或轻度,高为中度或明显。
- 整体队列中高腺体组织成分与更差的无病生存期相关(HR 1.42,95%CI 1.17–1.71,P<.001),与总生存期无关(HR 1.02,95%CI 0.81–1.30,P=.847)。
- 绝经后组中高腺体组织成分与更差的总生存期相关(HR 1.68,95%CI 1.15–2.46,P=.007),与更差的无病生存期相关(HR 1.43,95%CI 1.05–1.95,P=.022)。
- 三阴性乳腺癌中高腺体组织成分与更差的总生存期相关(HR 2.22,95%CI 1.28–3.87,P=.005),与更差的无病生存期相关(HR 1.61,95%CI 1.04–2.51,P=.035)。
临床应用与阅片要点
- 术前乳腺超声评估腺体组织成分时,可按轻微或轻度归为低、中度或明显归为高进行定性分级。
- 作者认为若进一步验证,该发现可能有助于在临床实践中细化预后风险分层。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Glandular tissue component (GTC) on screening breast ultrasound (US) is associated with breast cancer risk. However, the impact of GTC on survival outcomes in patients with invasive breast cancer remains unclear. This study aimed to evaluate the association between GTC on preoperative breast US and survival outcomes in women with invasive breast cancer.
MATERIALS AND METHODS: This retrospective study included 2889 patients with invasive breast cancer who underwent preoperative breast US between January 2013 and December 2018. GTC was qualitatively assessed on US and categorized as low (minimal or mild) or high (moderate or marked). Associations of GTC with disease-free survival (DFS) and overall survival (OS) were evaluated using Cox proportional hazards regression model. Subgroup analyses were conducted based on menopausal status and molecular subtype.
RESULTS: Of the 2889 patients, 966 (33.4%) had high GTC and 1923 (66.6%) had low GTC. In the overall cohort, high GTC was associated with worse DFS (hazard ratio [HR], 1.42 [95% CI: 1.17, 1.71]; P < .001), but not associated with OS (HR, 1.02 [95% CI: 0.81, 1.30]; P = .847). In the postmenopausal group, high GTC was associated with worse OS and DFS (HR, 1.68 [95% CI: 1.15, 2.46], P = .007; DFS: HR, 1.43 [95% CI: 1.05, 1.95], P = .022). In triple-negative breast cancers, high GTC was associated with worse OS and DFS (OS: HR, 2.22 [95% CI: 1.28, 3.87], P = .005; DFS: HR, 1.61 [95% CI: 1.04, 2.51], P = .035).
CONCLUSION: Glandular tissue component at preoperative breast US was independently associated with survival outcome in patients with invasive breast cancer. If further validated, this finding may help refine prognostic risk stratification in clinical practice.
引用
- Deng TT, Yan CJ, Lin QG, et al. Glandular Tissue Component on Breast Ultrasound: Association with Survival Outcomes in Women with Invasive Breast Cancer. Acad Radiol. 2025. PMID: 41421882. doi:10.1016/j.acra.2025.11.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。